Romgli Trademark Details

Romgli was registered on Tuesday, July 21, 2015 and is currently owned by Astrazeneca Ab under the registration number 4774996 . This mark is alive with a status of Registered. The last case file activity for this mark occured 8 years ago on Tuesday, July 21, 2015, according to the United State Patent & Trademark Office
Word Mark Romgli
Status Alive Registered 700 — Registered
Serial Number 85932452
Registration Number 4774996
Status Date Tuesday, July 21, 2015
Filing Date Tuesday, July 21, 2015
Registration Date Tuesday, July 21, 2015
Attorney Marc Stanislawczyk

Correspondent

Marc Stanislawczyk
ASTRAZENECA PHARMACEUTICALS LLP
1800 Concord Pike
FOP3-022
Wilmington, DE, 19850-5437

Case File Statements

Goods & Services Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Translation of Words in Mark The word(s) "ROMGLI" has no meaning in a foreign language.

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, May 23, 2013
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.